Table 3.
Tocilizumab | Historic cohort | |||||
---|---|---|---|---|---|---|
Full-blown | Possible | All | Full-blown | Possible | All | |
Number with sufficient data | 2 | 10 | 12 | 10 | 8 | 18 |
MAS (%, n) | 50 (1/2) | 20 (2/10) | 25 (3/12) | 90 (9/10) | 75 (6/8) | 83 (15/18) |
Reasons missing (n) | Afebrile [1] | Afebrile [4] | Afebrile [1] | Other markers [2] | ||
Ferritin [5] |
MAS Macrophage activation syndrome